Teva shares rise as company offers reassurance on former flagship drug Copaxone
November 07, 2019 at 16:02 PM EST
Teva Pharmaceutical Industries Ltd.’s third-quarter results underscore the realities of its two-year-old restructuring plan under president and CEO Kåre Schultz.
